NCT07586397 HIPS Feasibility Randomized Controlled Trial
| NCT ID | NCT07586397 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Massachusetts General Hospital |
| Condition | Hip Pain Chronic |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-07-20 |
| Primary Completion | 2027-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-07-20 with a primary completion date of 2027-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to conduct a randomized controlled trial (RCT) to test the feasibility of two dose- and time-matched pain management programs, delivered via live video, for adults with chronic (lasting at least 3 months) and non-arthritic hip-related pain (HRP). Following pre-determined benchmarks, findings from this trial will be used to assess the feasibility, credibility, and acceptability of both programs (HIPS-1, HIPS-2). In preparation for a future clinical trial powered to test efficacy, we will optimize the protocol for patient recruitment, study protocol, and fidelity materials.
Eligibility Criteria
Inclusion Criteria: 1. Presenting with chronic (lasting ≥3 months) hip joint-related pain 2. Fluent in English 3. Age ≥18yr \[If ≥45yr, the physician will confirm no osteoarthritis via X-ray (Kellgren Lawrence \[KL\] grade 0-1)\] 4. Score ≥3 for current hip pain on the Pain-VAS 5. Psychological risk factor for the maintenance of pain by meeting ≥1 of the criteria listed below: 1. Score ≥ 20 on the PCS 2. Score ≤ 40 on the PSEQ 3. Score ≥ 17 on the TSK-11 6. Exhibits sedentariness or dissatisfaction with physical activity by meeting ≥1 of the criteria listed below: 1. Physically active \< 150mins/week according to the IPAQ-SF 2. Hip pain interferes with the ability to be physically active 3. Dissatisfaction with the current physical activity level Exclusion Criteria: 1. Previous surgery on the symptomatic (painful) hip 2. Current pain referred from the lower back
Contact & Investigator
Kate Jochimsen, PhD, ATC
PRINCIPAL INVESTIGATOR
Massachusetts General Hospital
Frequently Asked Questions
Who can join the NCT07586397 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hip Pain Chronic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07586397 currently recruiting?
Yes, NCT07586397 is actively recruiting participants. Contact the research team at kjochimsen@mgh.harvard.edu for enrollment information.
Where is the NCT07586397 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT07586397 clinical trial?
NCT07586397 is sponsored by Massachusetts General Hospital. The principal investigator is Kate Jochimsen, PhD, ATC at Massachusetts General Hospital. The trial plans to enroll 50 participants.